- Home
- ALGT vs AUPH Comparison
ALGT vs AUPH Comparison
Compare ALGT & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGT
- AUPH
- Stock Information
- Founded
- ALGT 1997
- AUPH 1993
- Country
- ALGT United States
- AUPH Canada
- Employees
- ALGT N/A
- AUPH N/A
- Industry
- ALGT Air Freight/Delivery Services
- AUPH Biotechnology: Pharmaceutical Preparations
- Sector
- ALGT Consumer Discretionary
- AUPH Health Care
- Exchange
- ALGT Nasdaq
- AUPH Nasdaq
- Market Cap
- ALGT 1.5B
- AUPH 1.3B
- IPO Year
- ALGT 2006
- AUPH 1999
- Fundamental
- Price
- ALGT $93.31
- AUPH $8.88
- Analyst Decision
- ALGT Hold
- AUPH Strong Buy
- Analyst Count
- ALGT 9
- AUPH 3
- Target Price
- ALGT $73.78
- AUPH $10.33
- AVG Volume (30 Days)
- ALGT 309.5K
- AUPH 1.4M
- Earning Date
- ALGT 02-03-2025
- AUPH 02-13-2025
- Dividend Yield
- ALGT 1.27%
- AUPH N/A
- EPS Growth
- ALGT N/A
- AUPH N/A
- EPS
- ALGT N/A
- AUPH N/A
- Revenue
- ALGT $2,495,886,000.00
- AUPH $220,361,000.00
- Revenue This Year
- ALGT $1.60
- AUPH $36.97
- Revenue Next Year
- ALGT $11.25
- AUPH $16.43
- P/E Ratio
- ALGT N/A
- AUPH N/A
- Revenue Growth
- ALGT N/A
- AUPH 38.72
- 52 Week Low
- ALGT $36.09
- AUPH $4.71
- 52 Week High
- ALGT $94.52
- AUPH $10.67
- Technical
- Relative Strength Index (RSI)
- ALGT 74.36
- AUPH 51.68
- Support Level
- ALGT $80.57
- AUPH $8.91
- Resistance Level
- ALGT $92.22
- AUPH $9.31
- Average True Range (ATR)
- ALGT 4.01
- AUPH 0.32
- MACD
- ALGT 0.62
- AUPH -0.09
- Stochastic Oscillator
- ALGT 99.76
- AUPH 14.29
About ALGT Allegiant Travel Company
Allegiant Travel Co provides travel services in the United States. It sells air transportation on a stand-alone basis or bundled with air-related and third-party services and products. Customers may also purchase fixed-fee flying arrangements to receive charter service on a year-round and ad hoc basis. Additionally, customers may purchase hotel rooms, ground transportation, and other attractions (for example, entertainment show tickets) to accommodate a trip. The company's operating segment includes Airline, Sunseeker Resort, and other non-airlines. Customers purchase travel tickets at airport ticket counters, online, or through its telephone reservation center.
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.